F. F. (Russ) Knapp, Jr, Ph.D.
Corporate Fellow, Oak Ridge National Laboratory (ORNL)
Manager, Nuclear Medicine Program
Fuel Cycle and Isotopes Division
Dr. Knapp is formally trained as a biochemist and joined ORNL in the Biomedical Radioisotope Group in 1975 after completing postdoctoral training at Rice University and the University of Liverpool. He has headed the Nuclear Medicine Program since 1977. His research interest currently focus on the development and preclinical and clinical evaluation of radiopharmaceuticals with applications in nuclear medicine, oncology and interventional cardiology; reactor production and processing of medical radioisotopes; radionuclide generator development; and the use of radiotracers to evaluate gene-induced changes in metabolism effected by insulin sensitizing drugs in animal models of Type II diabetes.
EDUCATION AND TRAINING:
Clinic for Nuclear Medicine, Bonn, Germany, Alexander von Humboldt Fellow, 1991-1992
Clinic for Nuclear Medicine, Bonn, Germany, Visiting Scientist, 1985-1986
University of Liverpool, England, NIH Fellowship, 1970-1972
St. Louis University School of Medicine, St. Louis, MO, Ph.D. (1970), Biochemistry
Central College, Fayette, MO, B.S. (1966), Chemistry, Mathematics
PREVIOUS EMPLOYMENT AND EXPERIENCE:
Senior Scientist, Nuclear Medicine Program, Nuclear Science & Technology Division, 2001
Group Leader, Nuclear Medicine Program, Life Sciences Division, ORNL, 1978 - 2001
Research Staff Member, Oak Ridge National Laboratory (ORNL), 1975-1978
Senior Research Scientist, Biochemistry Department, Rice University, Houston, TX 1972-1975
HONORS:
Corporate Fellow, Oak Ridge National Laboratory, 1998.
Senior American Scientist ("Forschungspreistraeger"), Alexander von Humboldt Foundation, Clinic for Nuclear Medicine, University of Bonn, Bonn, Germany, 1991-1992.
Technical Achievement Award, Health and Safety Research Division, ORNL, 1987
Inventor Award, Martin Marietta Energy Systems, Inc., 1984
NIH and NATO Postdoctoral Fellow - 1970-1972
Phi Beta Kapp; A.B. cum laude
NSF (NASA) Graduate Fellow, Department of Biochemistry, St. Louis University School of Medicine, 1966-1970
RESEARCH INTERESTS:
Clinical applications of radioisotopes in nuclear medicine, oncology and interventional cardiology; effects of insulin sensitizing drugs on lipid metabolism in Type II diabetes; radionuclide generator development and applications; reactor production and processing of medical radioisotopes
EDITORIAL BOARDS:
World Journal of Nuclear Medicine (Beginning 2002)
Journal of Nuclear Medicine - 2000
European Journal of Nuclear Medicine - 1992 - 2000
Applied Radioisotopes and Technology - 1994 - present
Clinical Physiology, 1997- present
NucCompact/European-American Communications in Nuclear Medicine - 1989 - 1991
Oak Ridge National Laboratory (ORNL) Review - 1999 - present
Recent Organizing Committee Appointments:
Organizing Committee, Seventh International Radiopharmaceutical Dosimetry Symposium, Vanderbilt University, Nashville, TN, April 17-19, 2002
International Advisory Committee, Fourth International Conference on Isotopes (4ICI), Cape Town, South Africa, March 10-14, 2002
Institution Review Board, ORAU/ORNL, 1996-2201
Co-Organizer (With J. Kropp, M.D.), Fourth International Symposium on Radioiodinated Free Fatty Acids, Dresden, Germany, September 4-6, 1998
Organizer, Symposium on Radiopharmaceuticals, World Federation of Nuclear Medicine and Biology, Berlin, 1998
